Nektar Therapeutics Share Price Today: Live Updates & Key Insights
Nektar Therapeutics share price today is $72, up -3.5%. The stock opened at $75 against the previous close of $74.84, with an intraday high of $75.43 and low of $70.9.
Nektar Therapeutics Share Price Chart
Nektar Therapeutics
Nektar Therapeutics Share Price Performance
Nektar Therapeutics Institutional Holdings
Nektar Therapeutics Market Status
Nektar Therapeutics Fundamentals
Market Cap 2071.84 M
PB Ratio 23.9002
PE Ratio 0.0
Enterprise Value 1987.01 M
Total Assets 280.41 M
Volume 837535
Nektar Therapeutics Company Financials
About Nektar Therapeutics & investment objective
Company Information Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in the field of immunotherapy in the United States and internationally. It develops rezpegaldesleukin, which is in Phase 2b to treat underlying immune system imbalance in people with autoimmune disorders and inflammatory diseases; NKTR-0165 to treat ulcerative colitis, vitiligo, and multiple sclerosis; NKTR-0166 to treat autoimmune disease; NKTR-422 to treat fibrotic diseases; and NKTR-255 to treat solid tumors and large b-cell lymphoma. It has collaboration agreements with Takeda Pharmaceutical Company Ltd.; AstraZeneca AB; UCB Pharma; F. Hoffmann-La Roche Ltd; Bausch Health Companies Inc.; Pfizer Inc.; UCB Pharma (Biogen); Bristol-Myers Squibb Company; and Merck KGaA. The company was incorporated in 1990 and is headquartered in San Francisco, California.
Organisation Biotechnology
Employees 61
Industry Biotechnology
CEO Mr. Howard W. Robin
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Nektar Therapeutics FAQs
What is the share price of Nektar Therapeutics today?
The current share price of Nektar Therapeutics is $72.
Can I buy Nektar Therapeutics shares in India?
Yes, Indian investors can buy Nektar Therapeutics shares by opening an international trading and demat account with Motilal Oswal.
How to buy Nektar Therapeutics shares in India?
You can easily invest in Nektar Therapeutics shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Nektar Therapeutics shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Nektar Therapeutics.
Can I buy fractional shares of Nektar Therapeutics?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Nektar Therapeutics?
Nektar Therapeutics has a market cap of $2071.84 M.
In which sector does Nektar Therapeutics belong?
Nektar Therapeutics operates in the Biotechnology sector.
What documents are required to invest in Nektar Therapeutics stocks?
To invest, you typically need:
What is the PE and PB ratio of Nektar Therapeutics?
The PE ratio of Nektar Therapeutics is N/A and the PB ratio is 23.90.